Uranium Royalty Corp. UROY
4.14
(0.11)
(2.59%)
as of 25 Sep
- Market cap
- $1.6B
- P/E
- 10.8×
Follow UROY
Insider Buys
alert about insiders buying in the last 12 month
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.84 | 13.51 | 255.93 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.49 | 2.90 | 16.17 | 23.69 | |
P/FCF ratio |
2.58 | 3.05 | 22.93 | 30.36 | |
P/Operating CF |
10.08 | 3.56 | 108.83 | (226.49) | |
P/B ratio |
0.49 | 1.73 | 2.33 | 2.75 | |
Price to Tangible BV |
0.50 | 1.94 | 2.66 | 3.20 | |
EV/Sales |
4.72 | 1.36 | 13.82 | 21.80 | |
EV/EBITDA |
16.13 | 5.26 | 381.77 | 0.00 | |
EV/Operating CF |
4.86 | 1.43 | 18.97 | 27.17 | |
EV/FCF |
4.88 | 1.43 | 19.61 | 27.94 | |
Quick Ratio |
0.86 | 5.31 | 139.32 | 80.41 | |
Current Ratio |
0.88 | 5.94 | 325.30 | 265.75 | |
Net Debt/EBITDA |
28.82 | (6.36) | (46.74) | 25.99 | |
Debt/Assets |
31.01% | 0.02% | 0.03% | 0.04% | |
Debt/Equity |
0.54 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.20 | 0.63 | 0.16 | 0.12 | |
Operating CF/Net income |
3.26 | 4.19 | 4.16 | (1.95) | |
Capex/Depreciation |
0.00 | (1.09) | (0.02) | 0.26 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
1.87% | 0.75% | 7.82% | 6,391.53% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.15% | 0.11% | 1.61% | 1,084.41% | |
Graham Net Nets |
(1.31) | 0.50 | 0.36 | 0.30 | |
Graham Number |
7.76 | 3.82 | 0.88 | 0.00 | |
Earnings Yield |
11.31% | 7.40% | 0.39% | (0.05%) | |
Free Cash Flow Yield |
38.83% | 32.79% | 4.36% | 3.29% | |
Revenue per Share |
0.33 | 1.08 | 0.09 | 0.00 | |
Operating CF per Share |
0.34 | 1.09 | 0.04 | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.34 | 1.09 | 0.04 | (0.02) | |
Cash per Share |
0.73 | 2.12 | 0.71 | 0.44 | |
Shareholders Equity per Share |
6.96 | 2.25 | 1.94 | 1.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.96 | 2.25 | 1.94 | 1.77 | |
Free Cash Flow |
52.97 | 152.03 | 5.88 | (2.88) | |
Working Capital |
(17.25) | 273.82 | 233.17 | 195.71 | |
Capital Expenditures |
— | (0.01) | 0.00 | 0.01 | |
Net Current Asset Value |
(698.72) | 268.75 | 232.88 | 195.62 | |
EV/EBIT |
16.20 | 5.27 | 409.13 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | (0.37) | |
Net Profit Margin |
31.44% | 24.12% | 11.78% | 5,018.98% | |
Price to Operating Income |
8.54 | 11.22 | 478.56 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.11 | 0.05 | 0.02 | 5.14 | |
Average Payables |
16.25 | 1.41 | 0.71 | 0.84 | |
Average Inventory |
69.16 | 95.98 | 144.50 | 149.39 | |
Average Assets |
1,064.38 | 294.72 | 242.93 | 229.65 | |
Average Common Equity |
654.14 | 263.94 | 241.97 | 221.73 |
Columns are period end dates